Sigma Planning Corp’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.69M | Buy |
10,031
+3,766
| +60% | +$644K | 0.05% | 382 |
|
|
2025
Q4 | $1.06M | Buy |
6,265
+1,386
| +28% | +$225K | 0.03% | 514 |
|
|
2025
Q3 | $704K | Sell |
4,879
-137
| -3% | -$18.7K | 0.02% | 671 |
|
|
2025
Q2 | $635K | Sell |
5,016
-1,175
| -19% | -$144K | 0.02% | 688 |
|
|
2025
Q1 | $792K | Sell |
6,191
-182
| -3% | -$24.7K | 0.03% | 564 |
|
|
2024
Q4 | $843K | Sell |
6,373
-710
| -10% | -$99.8K | 0.03% | 551 |
|
|
2024
Q3 | $1.03M | Buy |
7,083
+743
| +12% | +$108K | 0.03% | 486 |
|
|
2024
Q2 | $870K | Buy |
6,340
+316
| +5% | +$42.2K | 0.03% | 522 |
|
|
2024
Q1 | $827K | Buy |
6,024
+2,896
| +93% | +$395K | 0.03% | 563 |
|
|
2023
Q4 | $425K | Sell |
3,128
-2,707
| -46% | -$330K | 0.03% | 509 |
|
|
2023
Q3 | $714K | Sell |
5,835
-975
| -14% | -$124K | 0.03% | 572 |
|
|
2023
Q2 | $865K | Sell |
6,810
-2,088
| -23% | -$271K | 0.03% | 525 |
|
|
2023
Q1 | $1.15M | Sell |
8,898
-3,991
| -31% | -$522K | 0.04% | 446 |
|
|
2022
Q4 | $1.69M | Buy |
12,889
+2,436
| +23% | +$315K | 0.06% | 324 |
|
|
2022
Q3 | $1.22M | Buy |
10,453
+1,807
| +21% | +$224K | 0.05% | 389 |
|
|
2022
Q2 | $1.02M | Buy |
8,646
+47
| +0.5% | +$5.58K | 0.04% | 460 |
|
|
2022
Q1 | $1.12M | Sell |
8,599
-637
| -7% | -$83K | 0.03% | 490 |
|
|
2021
Q4 | $1.41M | Sell |
9,236
-563
| -6% | -$87.2K | 0.04% | 422 |
|
|
2021
Q3 | $1.58M | Buy |
9,799
+951
| +11% | +$160K | 0.05% | 393 |
|
|
2021
Q2 | $1.45M | Sell |
8,848
-122
| -1% | -$18.8K | 0.04% | 423 |
|
|
2021
Q1 | $1.35M | Sell |
8,970
-490
| -5% | -$77.8K | 0.04% | 408 |
|
|
2020
Q4 | $1.43M | Buy |
9,460
+68
| +0.7% | +$9.72K | 0.05% | 349 |
|
|
2020
Q3 | $1.27M | Sell |
9,392
-1,394
| -13% | -$189K | 0.05% | 337 |
|
|
2020
Q2 | $1.47M | Buy |
10,786
+5,854
| +119% | +$746K | 0.06% | 289 |
|
|
2020
Q1 | $531K | Sell |
4,932
-1,119
| -18% | -$129K | 0.03% | 472 |
|
|
2019
Q4 | $729K | Sell |
6,051
-123
| -2% | -$13.7K | 0.03% | 485 |
|
|
2019
Q3 | $614K | Sell |
6,174
-532
| -8% | -$55.7K | 0.03% | 510 |
|
|
2019
Q2 | $732K | Buy |
6,706
+1,324
| +25% | +$141K | 0.04% | 430 |
|
|
2019
Q1 | $602K | Sell |
5,382
-337
| -6% | -$37K | 0.03% | 465 |
|
|
2018
Q4 | $552K | Sell |
5,719
-3,175
| -36% | -$337K | 0.04% | 408 |
|
|
2018
Q3 | $1.08M | Buy |
8,894
+409
| +5% | +$48.2K | 0.06% | 285 |
|
|
2018
Q2 | $932K | Buy |
8,485
+803
| +10% | +$85.9K | 0.06% | 304 |
|
|
2018
Q1 | $820K | Buy |
7,682
+56
| +0.7% | +$6.21K | 0.06% | 308 |
|
|
2017
Q4 | $814K | Sell |
7,626
-597
| -7% | -$63.8K | 0.06% | 306 |
|
|
2017
Q3 | $914K | Buy |
8,223
+1,368
| +20% | +$146K | 0.08% | 264 |
|
|
2017
Q2 | $709K | Sell |
6,855
-84
| -1% | -$8.27K | 0.07% | 321 |
|
|
2017
Q1 | $678K | Sell |
6,939
-903
| -12% | -$86.4K | 0.07% | 313 |
|
|
2016
Q4 | $694K | Buy |
7,842
+39
| +0.5% | +$3.55K | 0.08% | 281 |
|
|
2016
Q3 | $753K | Buy |
7,803
+105
| +1% | +$9.99K | 0.09% | 247 |
|
|
2016
Q2 | $660K | Buy |
7,698
+1,209
| +19% | +$108K | 0.09% | 261 |
|
|
2016
Q1 | $564K | Sell |
6,489
-8,925
| -58% | -$798K | 0.08% | 285 |
|
|
2015
Q4 | $1.74M | Sell |
15,414
-1,302
| -8% | -$141K | 0.24% | 93 |
|
|
2015
Q3 | $1.69M | Buy |
16,716
+2,052
| +14% | +$246K | 0.27% | 86 |
|
|
2015
Q2 | $1.8M | Buy |
14,664
+1,296
| +10% | +$155K | 0.25% | 97 |
|
|
2015
Q1 | $1.53M | Buy |
13,368
+7,596
| +132% | +$838K | 0.2% | 127 |
|
|
2014
Q4 | $584K | Buy |
+5,772
| New | +$561K | 0.08% | 305 |
|
Other funds holding IBB
CB
Sigma Planning Corp's IBB Position: Q1 2026 in Review
Sigma Planning Corp increased its iShares Biotechnology ETF (IBB) stake by 60% in Q1 2026, buying an estimated $644K and bringing the position to 10,031 shares worth $1.69M. The position accounts for 0.05% of the portfolio, ranked #382.
Sigma Planning Corp first reported a position in IBB in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.8M in Q2 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Sigma Planning Corp held 10,031 shares of iShares Biotechnology ETF worth $1.69M as of Q1 2026.
- Sigma Planning Corp bought 3,766 iShares Biotechnology ETF shares in Q1 2026, an estimated $644K.
- iShares Biotechnology ETF made up 0.05% of Sigma Planning Corp's portfolio in Q1 2026, its #382 holding.
- Sigma Planning Corp first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 46 quarters since.
- Sigma Planning Corp's iShares Biotechnology ETF position peaked at $1.8M in Q2 2015.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.